GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Additional Paid-In Capital

WuXi XDC Cayman (HKSE:02268) Additional Paid-In Capital : HK$1,406 Mil(As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Additional Paid-In Capital?


WuXi XDC Cayman's quarterly additional paid-in capital increased from Dec. 2022 (HK$1,435 Mil) to Mar. 2023 (HK$1,464 Mil) but then stayed the same from Mar. 2023 (HK$1,464 Mil) to Jun. 2023 (HK$1,406 Mil).

WuXi XDC Cayman's annual additional paid-in capital increased from Dec. 2021 (HK$0 Mil) to Dec. 2022 (HK$1,435 Mil) and increased from Dec. 2022 (HK$1,435 Mil) to Dec. 2023 (HK$5,349 Mil).

WuXi XDC Cayman Additional Paid-In Capital Historical Data

The historical data trend for WuXi XDC Cayman's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Additional Paid-In Capital Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
- - 1,435.14 5,348.87

WuXi XDC Cayman Quarterly Data
Dec20 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial - 1,435.14 1,463.77 1,405.66 5,348.87

WuXi XDC Cayman Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

WuXi XDC Cayman Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman (HKSE:02268) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Additional Paid-In Capital
Comparable Companies
Traded in Other Exchanges
L74:Germany
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
Website
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman (HKSE:02268) Headlines

No Headlines